Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Total Non-Current Liabilities (2021 - 2026)

Prokidney's (PROK) quarterly Total Non-Current Liabilities came in at $25.1 million in Q2 2026, down 21.0% year-over-year from $31.8 million in Q2 2025, and down 12.24% quarter-over-quarter from $28.6 million in Q1 2026.

Analysis

Prokidney (PROK) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

Prokidney (PROK) has reported Total Non-Current Liabilities for 6 consecutive years, with $25.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 21.0% year-over-year to $25.1 million in Q2 2026; TTM through Jun 2026 was $25.1 million, a 21.0% decrease from a year earlier, with the FY2025 full-year figure at $33.7 million, down 12.87% from the prior year.
  • Total Non-Current Liabilities was $25.1 million for Q2 2026 at Prokidney, down from $28.6 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $38.7 million in Q4 2024 and troughed at $11.6 million in Q3 2022.
  • A 5-year average of $26.4 million and a median of $27.7 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities jumped 124.18% in 2023 and dropped 21.0% in 2026, its largest moves.
  • Over 5 years, Total Non-Current Liabilities stood at $12.8 million in 2022, then jumped by 124.18% to $28.6 million in 2023, then soared by 35.05% to $38.7 million in 2024, then slipped by 12.87% to $33.7 million in 2025, then declined by 25.52% to $25.1 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $25.1 million (Q2 2026), $28.6 million (Q1 2026), and $33.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 134.44 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - 898.00 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 72.64 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 117.70 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 577.71 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 313.33 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 126.64 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 1.66 Bn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 130.91 Mn
10 Prokidney 346.07 Mn 346.07 Mn - 25.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.10 Mn
Mar 31, 2026 28.61 Mn
Dec 31, 2025 33.71 Mn
Sep 30, 2025 32.31 Mn
Jun 30, 2025 31.78 Mn
Mar 31, 2025 35.32 Mn
Dec 31, 2024 38.69 Mn
Sep 30, 2024 30.55 Mn
Jun 30, 2024 26.23 Mn
Mar 31, 2024 24.16 Mn
Dec 31, 2023 28.65 Mn
Sep 30, 2023 23.10 Mn
Jun 30, 2023 26.78 Mn
Mar 31, 2023 13.75 Mn
Dec 31, 2022 12.78 Mn
Sep 30, 2022 11.56 Mn
Dec 31, 2021 13.38 Mn